Correlation Between Evogene and BioLineRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evogene and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and BioLineRx, you can compare the effects of market volatilities on Evogene and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and BioLineRx.

Diversification Opportunities for Evogene and BioLineRx

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Evogene and BioLineRx is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Evogene i.e., Evogene and BioLineRx go up and down completely randomly.

Pair Corralation between Evogene and BioLineRx

Given the investment horizon of 90 days Evogene is expected to generate 0.35 times more return on investment than BioLineRx. However, Evogene is 2.86 times less risky than BioLineRx. It trades about -0.21 of its potential returns per unit of risk. BioLineRx is currently generating about -0.39 per unit of risk. If you would invest  190.00  in Evogene on November 4, 2024 and sell it today you would lose (33.00) from holding Evogene or give up 17.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Evogene  vs.  BioLineRx

 Performance 
       Timeline  
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Evogene and BioLineRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evogene and BioLineRx

The main advantage of trading using opposite Evogene and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.
The idea behind Evogene and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio